Teva Pharmaceutical Industries (TEVA) Other Operating Expenses (2012 - 2026)
Teva Pharmaceutical Industries' (TEVA) quarterly Other Operating Expenses came in at $19.0 million in Q2 2026, up 575.0% YoY from $2.8 million in Q2 2025, and up 111.11% on a QoQ basis from $9.0 million in Q1 2026.
Teva Pharmaceutical Industries (TEVA) Other Operating Expenses (2012 - 2026) Analysis & Trends
Teva Pharmaceutical Industries (TEVA) has 12 years of Other Operating Expenses data on file, last reported at $19.0 million in Q2 2026.
- Quarterly Other Operating Expenses rose 575.0% year-over-year to $19.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $18.0 million (up 350.0% YoY) and the FY2025 annual result came in at -$18.0 million, down 228.57% from the prior year.
- Other Operating Expenses improved to $19.0 million in Q2 2026, from $9.0 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $52.0 million in Q1 2022 to a low of -$8.0 million in Q4 2024.
- A 5-year average of $10.0 million and a median of $4.0 million in 2022 frame the typical range for Other Operating Expenses.
- Annual changes were most pronounced in 2022 — Other Operating Expenses surged 940.0% — and 2025, when it tumbled 400.0%.
- Tracing TEVA's Other Operating Expenses over 5 years: stood at $19.0 million in 2022, then tumbled by 68.42% to $6.0 million in 2023, then slumped by 233.33% to -$8.0 million in 2024, then jumped by 62.5% to -$3.0 million in 2025, then jumped by 733.33% to $19.0 million in 2026.
- The last three Other Operating Expenses figures came in at $19.0 million (Q2 2026), $9.0 million (Q1 2026), and -$3.0 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.71 Bn | 42.75 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.11 Bn | 39.45 Bn | 2.15 Bn |
| 3 | Zoetis | 31.62 Bn | 29.94 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.72 Bn | 22.92 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.33 Bn | 19.67 Bn | 683.80 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.10 Bn | 11.57 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Alkermes | 8.25 Bn | 7.60 Bn | 397.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 19.00 Mn |
| Mar 31, 2026 | 9.00 Mn |
| Dec 31, 2025 | -3.00 Mn |
| Sep 30, 2025 | -7.00 Mn |
| Jun 30, 2025 | -4.00 Mn |
| Mar 31, 2025 | -5.00 Mn |
| Dec 31, 2024 | -8.00 Mn |
| Sep 30, 2024 | 21.00 Mn |
| Jun 30, 2024 | 2.00 Mn |
| Mar 31, 2024 | -1.00 Mn |
| Dec 31, 2023 | 6.00 Mn |
| Sep 30, 2023 | 9.00 Mn |
| Jun 30, 2023 | 33.00 Mn |
| Mar 31, 2023 | 2.00 Mn |
| Dec 31, 2022 | 19.00 Mn |
| Sep 30, 2022 | 2.00 Mn |
| Jun 30, 2022 | 34.00 Mn |
| Mar 31, 2022 | 52.00 Mn |
| Dec 31, 2021 | 25.00 Mn |
| Sep 30, 2021 | 25.00 Mn |